Cathay Biotech Inc. (SHA:688065)
49.73
+0.43 (0.87%)
Nov 7, 2025, 3:00 PM CST
Cathay Biotech Market Cap
Cathay Biotech has a market cap or net worth of 35.84 billion as of November 7, 2025. Its market cap has increased by 27.17% in one year.
Market Cap
35.84B
Enterprise Value
30.73B
Revenue
3.29B
Ranking
n/a
PE Ratio
54.19
Stock Price
49.73
Market Cap Chart
Since August 12, 2020, Cathay Biotech's market cap has decreased from 65.42B to 35.84B, a decrease of -45.22%. That is a compound annual growth rate of -10.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 35.84B | 58.89% |
| Dec 31, 2024 | 22.56B | -29.54% |
| Dec 29, 2023 | 32.01B | -10.45% |
| Dec 30, 2022 | 35.75B | -53.44% |
| Dec 31, 2021 | 76.79B | 116.67% |
| Dec 31, 2020 | 35.44B | -45.83% |
| Aug 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zijin Mining Group Company | 797.03B |
| CMOC Group | 348.60B |
| Wanhua Chemical Group | 204.33B |
| China Northern Rare Earth (Group) High-Tech Co.,Ltd | 174.50B |
| Baoshan Iron & Steel | 165.66B |
| Shandong Gold Mining | 157.13B |
| Ningxia Baofeng Energy Group | 140.66B |
| Hengli Petrochemical | 136.49B |